Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vestergaard

Showing results (471-480 of 520) with videos related to

Pageof 52
Sort By:
Diabetes, Obesity & Metabolism|July 28, 2023
The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitusVeerle van Hulten, Johanna H M Driessen, Jakob K Starup-Linde, et al.
Current Drug Safety|August 10, 2020
Use of Sodium-Glucose Co-Transporter-2-Inhibitors (SGLT2-Is) and Risk of Lower Limb AmputationNikki C C Werkman, Johannes T H Nielen, Joop P W van den Bergh, et al.
Trials|November 8, 2024
The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial: study protocol for a randomized controlled trialCamilla H N Thomsen, Jannie T D Nørlev, Stine Hangaard, et al.
JBMR Plus|November 27, 2019
Urban-Rural Differences in Hip Fracture Mortality: A Nationwide NOREPOS StudySiri M Solbakken, Jeanette H Magnus, Haakon E Meyer, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 17, 2021
Incidence, hospitalization and mortality and their changes over time in people with a first ever diabetic foot ulcerJohan Røikjer, Nikki C C Werkman, Niels Ejskjaer, et al.
Diabetologia|February 1, 2025
Birthweight and risk of chronic kidney disease after a type 2 diabetes diagnosis in the DD2 cohortAleksander L Hansen, Christian F Christiansen, Charlotte Brøns, et al.
Diabetes Research and Clinical Practice|May 17, 2025
Educational inequalities in clinical presentation and pharmacological treatment of early type 2 diabetes: A Danish prevalence studyMarie T Sørensen, Frederik P B Kristensen, Jens S Nielsen, et al.
European Thyroid Journal|September 28, 2022
Cut-offs for thyroid peroxidase and thyroglobulin antibodies in early pregnancyStine Linding Andersen, Niels Henrik Bruun, Peter Astrup Christensen, et al.
Plos One|May 18, 2021
Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis RegistryViktoria Papp, Mathias Due Buron, Volkert Siersma, et al.
Current Drug Safety|November 13, 2013
CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysisJakob Starup-Linde, Oystein Karlstad, Stine Aistrup Eriksen, et al.
Pageof 52

Showing results (471-480 of 520) with videos related to

Sort By:
Pageof 52
Diabetes, Obesity & Metabolism|July 28, 2023
The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitusVeerle van Hulten, Johanna H M Driessen, Jakob K Starup-Linde, et al.
Current Drug Safety|August 10, 2020
Use of Sodium-Glucose Co-Transporter-2-Inhibitors (SGLT2-Is) and Risk of Lower Limb AmputationNikki C C Werkman, Johannes T H Nielen, Joop P W van den Bergh, et al.
Trials|November 8, 2024
The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial: study protocol for a randomized controlled trialCamilla H N Thomsen, Jannie T D Nørlev, Stine Hangaard, et al.
JBMR Plus|November 27, 2019
Urban-Rural Differences in Hip Fracture Mortality: A Nationwide NOREPOS StudySiri M Solbakken, Jeanette H Magnus, Haakon E Meyer, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 17, 2021
Incidence, hospitalization and mortality and their changes over time in people with a first ever diabetic foot ulcerJohan Røikjer, Nikki C C Werkman, Niels Ejskjaer, et al.
Diabetologia|February 1, 2025
Birthweight and risk of chronic kidney disease after a type 2 diabetes diagnosis in the DD2 cohortAleksander L Hansen, Christian F Christiansen, Charlotte Brøns, et al.
Diabetes Research and Clinical Practice|May 17, 2025
Educational inequalities in clinical presentation and pharmacological treatment of early type 2 diabetes: A Danish prevalence studyMarie T Sørensen, Frederik P B Kristensen, Jens S Nielsen, et al.
European Thyroid Journal|September 28, 2022
Cut-offs for thyroid peroxidase and thyroglobulin antibodies in early pregnancyStine Linding Andersen, Niels Henrik Bruun, Peter Astrup Christensen, et al.
Plos One|May 18, 2021
Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis RegistryViktoria Papp, Mathias Due Buron, Volkert Siersma, et al.
Current Drug Safety|November 13, 2013
CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysisJakob Starup-Linde, Oystein Karlstad, Stine Aistrup Eriksen, et al.
Pageof 52